HOOK HOOKIPA Pharma Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: HOOK

Price (delayed)

$0.9302

Market cap

$92.04M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.86

Enterprise value

-$18.49M

HOOKIPA Pharma Inc. is a clinical-stage biopharmaceutical company developing a new class of immunotherapeutics based on its proprietary arenavirus platform that reprograms the body's immune system.

Highlights
The revenue has increased by 41% YoY but it has decreased by 2% QoQ
HOOKIPA Pharma's gross profit has increased by 41% YoY but it has decreased by 2% QoQ
The debt has surged by 70% since the previous quarter
HOOK's net income is down by 26% year-on-year and by 18% since the previous quarter
Sector: Healthcare
Industry: Biotechnology
Website: http://www.hookipapharma.com
Peers: OPTN OPK ORGO

Key stats

What are the main financial stats of HOOK
Market
Shares outstanding
98.95M
Market cap
$92.04M
Enterprise value
-$18.49M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
0.87
Price to sales (P/S)
3.88
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
-0.92
Earnings
Revenue
$20.13M
EBIT
-$80.9M
EBITDA
-$77.34M
Free cash flow
-$61.68M
Per share
EPS
-$0.86
Free cash flow per share
-$0.73
Book value per share
$1.07
Revenue per share
$0.24
TBVPS
$1.92
Balance sheet
Total assets
$161.34M
Total liabilities
$71.48M
Debt
$6.56M
Equity
$89.86M
Working capital
$105.13M
Liquidity
Debt to equity
0.07
Current ratio
3.5
Quick ratio
3.25
Net debt/EBITDA
1.43
Margins
EBITDA margin
-384.2%
Gross margin
100%
Net margin
-405.3%
Operating margin
-485.3%
Efficiency
Return on assets
-48%
Return on equity
-85.7%
Return on invested capital
-567.5%
Return on capital employed
-67.8%
Return on sales
-401.9%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

HOOK stock price

How has the HOOKIPA Pharma stock price performed over time
Intraday
1.11%
1 week
4.52%
1 month
20.96%
1 year
-22.48%
YTD
14.84%
QTD
30.65%

Financial performance

How have HOOKIPA Pharma's revenue and profit performed over time
Revenue
$20.13M
Gross profit
$20.13M
Operating income
-$97.69M
Net income
-$81.58M
Gross margin
100%
Net margin
-405.3%
The revenue has increased by 41% YoY but it has decreased by 2% QoQ
HOOKIPA Pharma's gross profit has increased by 41% YoY but it has decreased by 2% QoQ
The company's operating income fell by 34% YoY and by 22% QoQ
HOOK's net income is down by 26% year-on-year and by 18% since the previous quarter

Growth

What is HOOKIPA Pharma's growth rate over time

Valuation

What is HOOKIPA Pharma stock price valuation
P/E
N/A
P/B
0.87
P/S
3.88
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
-0.92
The EPS has grown by 13% YoY but it has contracted by 4.9% from the previous quarter
The P/B is 45% above the last 4 quarters average of 0.6 but 38% below the 5-year quarterly average of 1.4
The company's equity fell by 12% YoY and by 5% QoQ
The price to sales (P/S) is 61% lower than the 5-year quarterly average of 9.9 but 34% higher than the last 4 quarters average of 2.9
The revenue has increased by 41% YoY but it has decreased by 2% QoQ

Efficiency

How efficient is HOOKIPA Pharma business performance
The company's return on invested capital has shrunk by 181% YoY and by 59% QoQ
HOOKIPA Pharma's return on equity has shrunk by 64% YoY and by 22% QoQ
The ROA is down by 28% YoY and by 20% from the previous quarter
The ROS has contracted by 21% from the previous quarter but it has grown by 11% YoY

Dividends

What is HOOK's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for HOOK.

Financial health

How did HOOKIPA Pharma financials performed over time
The total assets is 126% more than the total liabilities
HOOKIPA Pharma's current ratio has decreased by 15% YoY
HOOK's quick ratio is down by 14% YoY
The debt is 93% smaller than the equity
HOOKIPA Pharma's debt to equity has surged by 75% QoQ and by 17% YoY
The debt has surged by 70% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.